Zusammenfassung
Seit der Einführung von Flumazenil, einem kompetitiven Antagonisten, bietet sich die Möglichkeit, das Prinzip von Actio und Reactio, das für natürliche Steuerungsprozesse evolutionär ausgebildet und für die Feinsteuerung von Lebensvorgängen nahezu unerläßlich ist, nicht nur für den Bereich der nichtdepolarisierenden Muskelrelaxanzien und Opiate anzuwenden, sondern auch den Benzodiazepineinsatz in Anästhesie und Intensivmedizin nach diesem Prinzip zu erleichtern.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Artru A (1989) Flumazenil reversal of midazolam in dogs: Dose related changes in cerebral blood flow, metabolism, EEG, and CSF pressure. J Neurosurg Anesth 1: 46–55
Artru A (1990) The rate of CSF formation, resistance to reabsorption of CSF, and aperiodic analysis of the EEG following administration of flumazenil to dogs. Anesthesiology 72: 111–117
Ashton HC (1989) Benzodiazepine overdose: are specific antagonists useful? Br Med J 290: 805–806
Bodenham AR (1989) Death after flumazenil. Br Med J 299: 457
Bradley M, Wray R, Leach A, Nama M (1989) Flumazenil causing convulsions and ventricular tachycardia. Br Med J 299: 860
Burr W, Sandham P, Judd A (1989) Death after flumazenil. Br Med J 298: 1713
Chiolero RL, Ravussin P, Anderes JP,Tribolet N de, Freeman J (1986) Midazolam reversal with Ro 15–1788 in patients with sever head injury. Anesthesiology 65: A 358
Darragh A, Lambe R, Kenny M, Brick I (1983) Tolerance of healthy volunteers to intravenous administration of the benzodiazepine antagonist Ro 15–1788. Eur J Clin Pharmacol 24: 569–570
Duka T, Ackenheil M, Noderer J, Doenicke A, Dorow R (1986) Changes in noradrenaline plasma levels and behavioural responses induced by benzodiazepine agonists with the benzodiazepine antagonist Ro 15–1788. Psychopharmacology 90: 531–537
Fleischer JE, Milde JH, Moyer TP, Michenfelder JD (1988) Cerebral effects of high dose midazolam and subsequent reversal with Ro 15-1788 in dogs. Anesthesiology 68: 234–242
Forster A, Juge O, Louis M, Nahory A (1987) Effect of a specific benzodiazepine antagonist (Ro 15-1788) on cerebral blood flow. Anesth Analg 66: 309–313
Hruby K, Prischl F, Smetana R, Pernecker M, Donner A, Scholtz I, Grimm G (1987) Spezifische Therapie der akuten Benzodiazepinintoxikation mittels Flumazenil. MMW 137/9: 179–183
Klausen NO, Sorensen J, Ferguson AH, Neumann PB, Larsen C, Juhl O (1986) Stress response during recovery after total intravenous anaesthesia with midazolam and fentanyl reversed by Ro 15–1788. In: Beiträge zur Anaesthesiologie und Intensivmedizin 16: VII. European Congress of Anaesthesiology (abstr 133)
Kulka P, Lauven PM (1990) Comparison of two total intravenous anaesthesia techniques for laryngoscopic laser surgery under jet-ventilation: Midazolam/flumazenil vs. methohe-xital. Acta Anaesth Scand. 34 (Suppl 92): 90–96
Lauven PM, Kulka P (1988) Antagonisierung der Benzodiazepinwirkung mit Flumazenil (Ro 15-1788). Anästh Intensivther Notfallmed 23: 153–158
Lauven PM, Ebeling BJ, Stoeckel H, Dierke-Dzierzon C (1986) Wirksamkeit des Benzodiazepin-Antagonisten Ro 15-1788 nach einer Anästhesie mit Flunitrazepam-Einleitung. Anästh Intensivther Notfallmed 21: 311–314
Lim AG (1989) Death after flumazenil. Br Med J 299: 1531
Little HJ, Bichard R (1984) Differential effect of the benzodiazepam antagonist Ro 15-1788 after “general anaesthetic” doses of benzodiazepines in mice. Br J Anaesth 56: 1153–1159
Lukas SE, Griffiths R (1984) Precipitated diazepam withdrawel in baboons: Effects of dose and duration of diazepam exposure. Eur J Pharmacol 100: 163–171
Marty J, Nitenber A, Blanchet F, Zouioueche S, Desmonts JM (1986) Effects of midazolam on the coronary circulation in patients with coronary artery desease. Anaesthesiology 64: 206–210
Mora CT,Torjman M,White PF (1989) Effects of diazepam and flumazenil on sedation and hypoxic ventilatory response. Anesth Analg 68: 473–478
Polc P, Bonetti E, Cumin R, Laurent JP, Pieri L, Schaffner R, Scherschlicht R (1982) Neuropharmacology of the selective benzodiazepine antagonist Ro 15-1788. In: Usdin et al. (eds) Pharmacology of benzodiazepines. Macmillan, London, p 405
Raeder JC, Hole A, Arnulf V, Hougens Grynne B (1987) Total intravenous anaesthesia with midazolam and flumazenil. Acta Anaesth Scand 31: 634–641
Ritter JW, Hacke WE, Norel E, Gion H, Chen R, Hoskizaki G (1988) Adrenergic and hemodynamic response to flumazenil (Ro 15-1788) reversal of midazolam sedation. Anesthesiology 69: A 109
Schulte am Esch J, Kochs E (1990) Midazolam and flumazenil in neuroanaesthesia. Acta Anaesthesiol Scand 34/92: 96–102
Scollo-Lavizarri G (1983) First clinical investigation of the benzodiazepine antagonist Ro 15-1788 in comatose patients. Eur Neurol 22: 7–11
Smith DE (1979) Importance of gradual dosage reduction following low dose benzodiazepine therapy. Newslett Calif Soc Treat Alcohol Drug Depend 6: 1–3
Tolksdorf W, Pirwitz A, Bentzinger C, Pfeiffer J (1987) Ro 15-1788 antagonisiert zuverlässig die Benzodiazepin Wirkung nach Flunitrazepam-Kombinationsnarkosen. Anästhesist 36: 203–209
White PF, Shafer A, Boyle WA, Doze A van, Duncan S (1989) Benzodiazepine antagonism does not provoke a stress response. Anesthesiology 70: 636–639
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Lauven, P.M., Kulka, P. (1993). Nebenwirkungen und Risiken der Benzodiazepinantagonisierung. In: Rügheimer, E. (eds) Konzepte zur Sicherheit in der Anästhesie. Klinische Anästhesiologie und Intensivtherapie, vol 42. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77781-3_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-77781-3_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-55931-3
Online ISBN: 978-3-642-77781-3
eBook Packages: Springer Book Archive